The World Health Organization (WHO) has revealed that XE, the newest subspecies of Omicron, appears to be It is able to infect approximately 10% more than BA.2, which is also a subspecies of Omikron.
The WHO said in its weekly epidemiological report released March 29 that omikron strain XE is a cross between omikron strains BA.1 and BA.2, and XE will remain a strain. Subtypes of omikron until there are reports showing significant differences in transmission and disease characteristics, including severity.
The report states that “Early estimates indicate that XE has a community transmission rate of approximately 10% more than the BA.2 strain, however, this finding needs further confirmation.”
The WHO has identified the BA.2 subspecies as the main strain that is currently spreading around the world. It accounts for almost 86% of all infected people.
The XE strain was first detected in the UK on Jan. 19, and there have been more than 600 confirmed cases of XE since then.
Susan Hopkins, chief medical adviser for the UK’s Health Security Agency (HSA), said so far there is insufficient evidence to draw conclusions about the infectivity, severity or effectiveness of the drug. Vaccines to protect against XE strains
The WHO said it would continue to closely monitor and assess the public health risks associated with the virus hybrids such as the XE strain and will release more information as more evidence becomes available.
In addition to the XE strain, the WHO is also monitoring the XD strain, which is a cross between Delta and Omicron. It is found mainly in France, Denmark and Belgium.
The WHO has no evidence that COVID XD has the ability to infect more or cause more severe symptoms in any way.
By InfoQuest News Agency (02 Apr 65)
Tags: BA.2, COVID-19, lifestyle, World Health Organization, COVID-19, COVID-19 strain XE